Assessment of minimal residual disease in patients with acute leukemia

Current Opinion in Oncology

Volumn 10, Issue 1, 1998, Pages 17-22

  Baer, Maria R ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

ACUTE LEUKEMIA; BONE MARROW CELL; CANCER GENETICS; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION; DIAGNOSTIC PROCEDURE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HUMAN; IMMUNOGLOBULIN GENE; LEUKEMIA CELL; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0031975737     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-199801000-00004     Document Type: Review

References (24)

1. Campagna D, Pui C-H: Detection of minimal residual disease in acute leukemia: methodological advances and clinical significance. Blood 1995, 85:1416-1434.
2. Miller WH, Levine K, DeBlasio A, Frankel SR, Dmitrovsky E, Warrell RP: Detection of minimal residual disease In acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-α fusion mRNA. Blood 1993, 82:1689-1694.
3. Seale JRC, Varma S, Swirsky DM, Pandolfi P-P, Goldman JM, Cross NCP: Quantification of PML-RARα transcripts In acute promyelocytic leukaemia: explanation for the lack of sensitivity of RT-PCR for the detection of minimal residual disease and induction of the leukaemia-specific mRNA by alpha interferon. Br J Haematol 1996, 95:95-101.
4. Nucifora G, Larson RA, Rowley JD: Persistence of the 8;21 translocation in patients with acute myelold leukemia type M2 in long-term remission. Blood 1993, 82:712-715.
5. Miyamoto T, Nagafuji K, Akashi K, Harada M, Kyo T, Akashi T, Takenaka K, Mizuno S, Gondo H, Okamura T, et al.: Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia. Blood 1996, 87:4789-4796.
6. Jurlander J, Caligiuri MA, Ruutu T, Baer MR, Strout MP, Oberkircher AR, Hoffman L, Ball ED, Frei-Lahr DA, Christiansen NP, et al.: Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. Blood 1996, 88:2183-2191.
7. Tobal K, Yin JAL: Monitoring of minimal residual disease by quantitative reverse transcription-polymerase chain reaction for AML1-MTG8 transcripts in AML-M2 with t(8;21). Blood 1996, 88:3704-3709.
8. Muto A, Mori S, Matsushita H, Awaya N, Ueno H, Takayama NT, Okamoto S-I, Kizaki M, Ikeda Y: Serial quantification of minimal residual disease of t(8;21) acute myelogenous leukaemia with RT-competitive PCR assay. Br J Haematol 1996, 95:85-94.
9. Costello R, Sainty D, Biaise D, Gastaut JA, Gabert J, Poirel H, Buzynveil A, Macintyre E: Prognosis value of residual disease monitoring by poly merase chain reaction In patients with CBF beta/MYH11-positive acute myeloblastic leukemia. Blood 1997, 89:2222-2223.
10. Boer J, Mahmoud H, Raimondi S, Grosveld G, Krance R: Loss of the DEK-CAN fusion transcript in a child with t(6;9) acute myeloid leukemia following chemotherapy and allogeneic bone marrow transplantation. Leukemia 1997, 11:299-300.
11. Roberts WM, Estrov Z, Ouspenskaia MV, Johnston DA, McClain KL, Zipf TF: Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. N Engl J Med 1997, 336:317-323.
12. Greaves M: Silence of the leukemic clone [editorial]. N Engl J Med 1997, 336:367-369.
13. Brisco MJ, Hughes E, Neoh SH, Sykes PJ, Bradstock K, Enno A, Szer J, McCaul K, Morley AA: Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia. Blood 1996, 87:5251-5256.
14. Preudhomme C, Henic N, Cazin B, Laï JL, Bertheas MF, Vanrumbeke M, Lemoine F, Jouet JP, Deconninck E, Nelken B, et al.: Good correlation between RT-PCR analysis and relapse In Philadelphia (Ph1)-positive acute lymphoblastic leukemia (ALL). Leukemia 1997, 11:294-298.
15. Radich J, Gehly G, Lee A, Avery R, Bryant E, Edmands S, Gooley T, Kessler P, Kirk J, Ladne P, et al.: Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation. Blood 1997, 89:2602-2609.
16. Cayuela J-M, Baruchel A, Orange C, Madani A, Auclerc MF, Daniel M-T, Schaison G, Sigaux F: TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia. Blood 1996, 88:302-308.
17. Nakao M, Yokota S, Horiike S, Taniwaki M, Kashima K, Sonoda Y, Koizumi S, Takaue Y, Matsushita T, Fujimoto T, et al.: Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia. Leukemia 1996, 10:1463-1470.
18. Satake N, Kobayashi H, Tsunematsu Y, Kawasaki H, Horikoshi Y, Koizumi S, Kaneko Y: Minimal residual disease with TEL-AML1 fusion transcript in childhood acute lymphoblastic leukaemia with t(12;21). Br J Haematol 1997, 97:607-611.
19. Inoue K, Ogawa H, Yamagami T, Soma T, Tani Y, Tatekawa T, Oji Y, Tamaki H, Kyo T, Dohy H, et al.: Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms Tumor gene) expression levels. Blood 1996, 88:2267-2278.
20. El-Rifai W, Ruutu T, Elonen E, Volin L, Knuutila S: Prognostic value of metaphase-fluorescence in situ hybridization in follow-up of patients with acute myeloid leukemia in remission. Blood 1997, 89:3330-3334.
21. El-Rifai W, Ruutu T, Vettenranta K, Elonen E, Saarinen UM, Volin L, Knuutila S: Follow-up of RD using metaphase-FISH In patients with acute lymphoblastic leukemia in remission. Leukemia 1997, 11:633-638.
22. Kasprzyk A, Secker-Walker LM: Increased sensitivity of minimal RD detection by interphase FISH in acute lymphoblastic leukemia with hyperdiploidy. Leukemia 1997, 11:429-435.
23. Bernell P, Arvidsson I, Jacobsson B, Hast R: Fluorescence in situ hybridization in combination with morphology detects minimal RD in remission and heralds relapse in acute leukemia. Br J Haematol 1996, 95:666-672.
24. Sievers EL, Lange BJ, Buckley JD, Smith FO, Wells DA, Daigneault-Creech CA, Shults KE, Bernstein ID, Loken MR: Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry. J Natl Cancer Inst 1996, 88:1483-1488.